Drugplain

Anubis Barcelona .0006 g/60mL

DMAE, ZIRHAFIRM · CREAM · ANUBIS COSMETICS SL

No Recall History
Plain English

Anubis Barcelona is a topical cream used to treat lice infestations. This over-the-counter pediculicide contains dimethylaminoethanol and is applied directly to the skin or affected areas.

Key Facts

Brand Name
Anubis Barcelona
Generic Name
DMAE, ZIRHAFIRM
NDC Code (Product)
83021-553
Manufacturer
ANUBIS COSMETICS SL
Strength
.0006 g/60mL
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Application #
M016
Drug Class
Pediculicide [EPC]; Standardized Chemical Allergen [EPC]
Marketing Start
01/13/2023

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

fatigue7 reports
headache7 reports
arthralgia6 reports
insomnia6 reports
drug ineffective5 reports
feeling abnormal5 reports
pain5 reports
anxiety4 reports
weight decreased4 reports
arthritis3 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

NE Lotion Indications

Dosage & Administration

NE Lotion dosage

Warnings

NE Lotion warnings

Frequently Asked Questions

What is Anubis Barcelona used for?

Anubis Barcelona is a topical cream used to treat lice infestations. This over-the-counter pediculicide contains dimethylaminoethanol and is applied directly to the skin or affected areas.

Is Anubis Barcelona a controlled substance?

Anubis Barcelona is not classified as a controlled substance by the DEA.

What is the generic name for Anubis Barcelona?

The generic name for Anubis Barcelona is DMAE, ZIRHAFIRM. There are no other listed brand versions of DMAE, ZIRHAFIRM.

What is the NDC code for Anubis Barcelona .0006 g/60mL?

The NDC (National Drug Code) for Anubis Barcelona .0006 g/60mL is 83021-553, listed by ANUBIS COSMETICS SL.

Product NDC

83021-553

Package NDC

83021-553-60

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)